To explore parents' experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes, being followed in the Australian Environmental Determinants of Islet Autoimmunity (ENDIA) study.
Less than 20% of Australians with type 1 diabetes (T1D) meet recommended glucose targets. Technology use is associated with better glycaemia, with the most advanced being automated insulin delivery (AID) systems, which are now recommended as gold-st…
To determine the efficacy of advanced hybrid closed-loop therapy in a high-risk cohort of youth on continuous subcutaneous insulin infusion with or without continuous glucose monitoring with suboptimal glycemia.
The DiabHQ Patient Portal App is coming soon!
We are proud to have so many very talented children and youth in our T1D community.
Technology is an important part of diabetes management but its important to stay cybersecurity aware.
Dr Sabrina Binkowski
Christmas came early at the Monday diabetes clinic
What the national committee have been working on
Jo Lester, DiabHQ Steering Committee Member